Does bone marrow CXCR4 induction by cultivation enhance therapeutic angiogenesis?
The upregulation of CXCR4 expression by cultivation may serve as a useful source of BMCs for accelerating therapeutic angiogenesis in ischaemic cardiovascular diseases.
We propose that an antiangiogenic state may be present in some cases of TTTS.